key: cord-0993970-vd7nsg3t authors: Dionne-Odom, Jodie; Klipstein, Sigal title: The Impact of Epidemiology on Prenatal and Fertility Care during the COVID-19 Pandemic date: 2021-02-10 journal: Am J Epidemiol DOI: 10.1093/aje/kwab026 sha: 972ab14a298f7a4dfee2e23b576f2190a4de73c6 doc_id: 993970 cord_uid: vd7nsg3t The emergence of the novel coronavirus COVID-19 presented the field of reproductive medicine with many challenges due to an absence of data to guide clinical decision making and inform patient counseling and management in the early days of the pandemic. Epidemiological studies rapidly filled in key gaps in our understanding of the susceptibility of reproductive aged women to the virus, transmission dynamics during pregnancy and lactation, and the effect of infection during the prenatal, pregnancy and post-partum periods. This data guided the development of clinical guidelines written by the American Society for Reproductive Medicine as patients and clinicians navigated reproductive decisions during a time of uncertainty. We present a review of epidemiologic studies published between March and December 2020 that directly informed prenatal and fertility care during the COVID-19 pandemic. Despite a significant increase in our knowledge base over the past year, many questions remain about the impact of COVID-19 on conception, pregnancy, fetal development, and lactation. In the future, a commitment toward inclusion of pregnant persons and those attempting pregnancy in the design of observational and interventional trials is necessary to gain earlier insights about outcomes and assist providers and patients in making data driven decisions. at the onset of COVID-19 symptoms and 1-2 days prior. 6 Another small but highly impactful study from New York City led to immediate changes in screening policies in many US facilities. as they decide whether to attempt pregnancy, and to providers who need to know whether exposure in the first trimester is associated with an increased risk of spontaneous abortion, preterm delivery, congenital anomalies or neurological development, and whether specific subgroups of women are at increased risk. Another pivotal issue is vaccine uptake in women who are pregnant or planning pregnancy. Similar to COVID-19, women who contract influenza during pregnancy are at increased risk of severe disease and complications. 16 In US CDC surveillance, cumulative incidence of COVID-19 infection stratified by gender was similar. Men had higher rates of severe disease and death. Suggests that women age 18-49 may be at lower risk of severe COVID-19 compared to men and older adults. To, 2020 (5) This early case of COVID-19 reinfection was detected in an asymptomatic adult six months after an initial mild infection with a different SARS CoV2 strain. Reinforces to patients that prevention measures remain important even after COVID-19 infection. Szablewski, 2020 (4) The attack rate at an overnight summer camp in Georgia, was 56% among staff members (majority female, median age 17, age range 14-59). Highlights rapid transmissibility of COVID-19 with close and prolonged contact. Supports social distancing. He, 2020 (6) SARS CoV2 viral load levels peaked soon after symptom onset. Modeled the frequency of presymptomatic spread (44% of secondary cases). Suggests that COVID-19 transmission to women who are pregnant or seeking pregnancy can occur from asymptomatic carriers with high viral load. Sutton, 2020 (7) Most (29/33) women with COVID-19 detected by universal screening at delivery were asymptomatic. Supports universal COVID-19 screening at the time of delivery. Salvatore, 2020 No transmission events among 120 neonates born to women with COVID-19 in 3 NYC facilities with rooming in and breastfeeding. Reassuring in terms of neonatal transmission risk when masking and hand hygiene protocols are followed. Chambers, 2020 Among 5700 inpatients in NYC, <40% were female, median age was 63 years (IQR 52-75). Suggests that younger women are at lower risk of hospitalization with COVID-19 compared to older adults. Allotey, 2020 (14) Living systematic review of risk factors and outcomes of COVID-19 in pregnancy. Studies are heterogenous but key risk factors for severe disease included older age, obesity, chronic hypertension, and diabetes. Useful in counseling patients about individual risk levels and infection prevention strategies. Reviews are quickly outdated given the pace of publication on COVID-19. Afshar, 2020 (15) Prospective cohort study of 736 symptomatic pregnant/postpartum women with known or suspected COVID-19. Among those with symptoms, median 37 days to resolution. Initial report on maternal outcomes from registry (PRIORITY). Highlights benefit of collaborative efforts to track pregnancy outcomes. Zambrano, 2020 (16) CDC data on severe outcomes of COVID-19 in pregnancy (n=23,000). Adjusted risk ratio showed association between pregnancy and ICU admission, ventilation and mortality compared to non-pregnant women age 15-44. Useful to counsel pregnant women that they may be at higher risk of severe COVID-19 disease compared to nonpregnant women. Highlights racial disparities in outcomes. Woodworth, 2020 (17) CDC report of women with COVID-19 (n=5252) and birth outcomes. Preterm delivery 12.9% vs 10.2% historical control Useful to counsel patients about potential adverse pregnancy outcomes if they acquire COVID-19. Epidemiology is a science of high importance Coronavirus Disease 2019 Case Surveillance -United States SARS-CoV-2 Transmission and Infection Among Attendees of an Overnight Camp -Georgia COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing Temporal dynamics in viral shedding and transmissibility of COVID-19 Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. The New England journal of medicine Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. American journal of obstetrics and gynecology Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women ACOG Statement on COVID-19 and Pregnancy Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People. Obstetrics and gynecology Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status -United States Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy -SET-NET, 16 Jurisdictions Effects of influenza on pregnant women and infants. American journal of obstetrics and gynecology QuickStats: Percentage* of U.S. Adults Aged ≥18 Years Who Have Had a Flu Vaccination in the Past 12 Months,( †) by Sex and Age Group -National Health Interview Survey,( §) 2017. MMWR Morbidity and mortality weekly report Gallup Poll Survey. Willingness to Get COVID19 Vaccine in the US Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response. Vaccine Pregnant women's perceptions of risks and benefits when considering participation in vaccine trials. Vaccine